MedDataX Logo

Feasibility of Breast Cancer Risk Evaluation in Women From the General Population

NCT ID: NCT02997384

Last Updated: 2016-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-31

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the feasibility (acceptability) of a consultation dedicated to informing women about their risk of breast cancer and the screening methods recommended for them according to the recommendations in force during a routine consultation at a general practitioner, a gynecologist or a radiologist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breastcancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

General practitioner

Information

Intervention Type OTHER

information of women about their risk of breast cancer and the screening methods recommended for them

gynecologist

Information

Intervention Type OTHER

information of women about their risk of breast cancer and the screening methods recommended for them

radiologist

Information

Intervention Type OTHER

information of women about their risk of breast cancer and the screening methods recommended for them

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Information

information of women about their risk of breast cancer and the screening methods recommended for them

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Woman from 40 to 74 years old
* Understanding the French language

Exclusion Criteria

Women will not be eligible for study if they are in any of the following situations:

* Cancer active or in the course of treatment type surgery, chemotherapy, or radiotherapy, whether breast or other organ
* Recent diagnosis \<1 year of suspicious or cancerous lesions
* Psychiatric pathology not compatible with the study
* Poor understanding of the French language
Minimum Eligible Age

40 Years

Maximum Eligible Age

74 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gustave Roussy

Villejuif, Val de Marne, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016/2422

Identifier Type: OTHER

Identifier Source: secondary_id

2016-A01082-49

Identifier Type: -

Identifier Source: org_study_id